The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Mayo Clinic
- Study ID
- NCT07285044
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Amyloidosis
- Basal Cell Carcinoma
- Biliary Tract Carcinoma
- Bladder Carcinoma
- Breast Carcinoma
- Cervical Carcinoma
- Colorectal Carcinoma
- Endometrial Carcinoma
- Fallopian Tube Carcinoma
- Gastroesophageal Junction Carcinoma
- Glioblastoma
- Head and Neck Carcinoma
- Hematopoietic and Lymphatic System Neoplasm
- Hepatocellular Carcinoma
- Hodgkin Lymphoma
- Lung Carcinoma
- Malignant Solid Neoplasm
- Mantle Cell Lymphoma
- Melanoma
- Merkel Cell Carcinoma
- Multiple Myeloma
- Myelodysplastic Syndrome
- Ovarian Carcinoma
- Pancreatic Carcinoma
- Primary Peritoneal Carcinoma
- Prostate Carcinoma
- Renal Cell Carcinoma
- Squamous Cell Carcinoma
- Urothelial Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cancer Therapeutic Procedure — DRUGReceive in-home standard of care cancer-treatment
- Cancer Therapeutic Procedure — DRUGReceive in-clinic standard of care cancer-treatment
- Questionnaire Administration — OTHERAncillary studies
Study Details
This phase II trial studies whether providing cancer treatment in the home is preferred over the traditional clinic setting and if it improves treatment satisfaction in cancer patients living in the Florida Panhandle and surrounding areas. Typically, drug-related cancer care is provided at a medical center which causes patients to have to spend considerable time away from their family, friends, and familiar surroundings. This may add to the physical, emotional, social, and financial burden for patients and their families during this difficult time in their lives. The Cancer Connected Access and Remote Expertise (CARE) Beyond Walls (CCBW) program uses a specialized care team trained to provide cancer treatment in the patient's home setting. It is designed to support remote connection between the home health team and providers and Mayo clinic. This may be preferred over the traditional clinic setting which may improve treatment satisfaction in cancer patients living in the Florida Panhandle and surrounding areas.
Key Dates
- Start date
- Dec 18, 2025
- Status verified
- May 2026
- Primary completion
- Dec 18, 2026
- Completion
- Dec 18, 2026
Study Design
- Enrollment
- 27 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Health services research (CCBW in-home cancer treatment)Patients receive in-home standard of care cancer-treatment through CCBW according to standard clinical practice for up to 12 weeks in the absence of disease progression or unacceptable toxicity. Following 12 weeks of in-home treatment, patients choose to return to clinic setting or continue to receive in-home treatment for an additional 12 weeks.
Primary Outcome Measure
Patient preferences regarding location of cancer treatment delivery [ Time Frame: At 12 weeks ]
Central Contacts
- Clinical Trials Referral Office855-776-0015
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Florida | Jacksonville | Florida | 32224-9980 | Roxana S. Dronca, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Jacksonville, FL
Related Studies
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)Recruiting · Center for International Blood and Marrow Transplant Research · Birmingham, Alabama
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Project: Every Child for Younger Patients With CancerRecruiting · Children's Oncology Group · Birmingham, Alabama
- TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerPHASE2 · Recruiting · American Society of Clinical Oncology · Birmingham, Alabama